Weight Loss Injections Could Weaken Birth Control, Warn UK Regulators

Unplanned pregnancies are popping up in stories from people using Ozempic, Wegovy, and Mounjaro, even though they were on contraception. The UK regulator, MHRA, has issued a fresh warning after reports that these weight loss injections may interfere with birth control effectiveness.

Here’s the messy part: GLP-1 receptor agonists like semaglutide and tirzepatide can slow stomach emptying, which may affect how well oral contraceptives absorb. And then there’s the twist nobody wants to deal with, weight loss can also change fertility, so the outcome can feel like it came out of nowhere.

It started with a few “how did this happen?” moments, and now the Yellow Card reports are adding fuel to the concern.

The warning follows reports of unplanned pregnancies on Ozempic, Wegovy, and Mounjaro despite contraception.

Dr. Alison Cave of the MHRA stresses that these drugs are medical treatments, not cosmetic quick fixes, and patients should always follow professional guidance and read medication leaflets. Experts agree that these drugs may slow stomach emptying, reducing oral contraceptive absorption, although more research is needed.

Given the unclear risks to pregnancy and evidence that other weight loss methods can increase miscarriage chances, women are advised to take extra precautions to avoid pregnancy.

Shutterstock

Deb Oliviara revealed she got pregnant on Ozempic and stopped it as soon as she knew.

Reports from women using these drugs confirm unexpected pregnancies, sometimes linked to increased fertility after weight loss, but in some cases due to reduced contraceptive effectiveness. One woman in the US shared how semaglutide made birth control less effective while also boosting fertility, prompting her to stop the drug once she became pregnant.

These weight loss injections belong to the GLP-1 receptor agonist class, which mimics natural fullness hormones. Mounjaro also affects a second hormone related to appetite and blood sugar.

The MHRA tracks side effects through its Yellow Card scheme, which monitors drug safety in the UK. This system was established after the 1960s thalidomide scandal and helps detect adverse reactions, leading to warnings or drug withdrawals if necessary.

TikTok

That’s when the MHRA warning hit, after reports tied to Ozempic, Wegovy, and Mounjaro despite contraception.

Deb Oliviara’s story, getting pregnant on Ozempic and stopping it as soon as she found out, made the risk feel painfully real.

To sum up, women using weight loss injections must take effective contraception to prevent pregnancy. If pregnancy occurs, they should stop the medication right away.

It’s also important to avoid unregulated or unofficial products, as these could pose serious health risks. While these injections can be valuable for managing weight, they come with potential side effects and risks that require close attention and responsible use to ensure safety.

This is similar to the 70-year-old man who discovered a major heart condition thanks to his mattress.

Meanwhile, another woman’s account from the US claimed semaglutide made her birth control less effective while also boosting fertility, so she stopped once she became pregnant.

Implications of Hormonal Interactions

Using dual contraceptive methods, such as condoms alongside hormonal birth control, can mitigate risks of unintended pregnancies. This strategy is recommended by health professionals to maintain reproductive autonomy while pursuing weight loss goals.

Healthcare providers should offer comprehensive counseling, discussing the necessity of additional contraceptive methods for patients on Mounjaro or similar medications. This proactive approach not only empowers patients but also reinforces their understanding of how weight loss therapies can impact overall health.

And once the MHRA’s Yellow Card scheme starts tracking these reactions, the conversation shifts from “rare” to “watch this closely,” especially with unregulated products in the mix.

The recent warning from the Medicines and Healthcare products Regulatory Agency about weight loss injections like Ozempic, Wegovy, and Mounjaro underscores the critical need for informed healthcare decisions, particularly regarding contraception. The potential for these drugs to diminish the effectiveness of birth control raises significant concerns for users. To mitigate this risk, employing dual contraceptive methods may serve as a prudent strategy for those undergoing treatment with these medications.

Education and proactive discussions with healthcare providers are essential in navigating these complexities. Individuals must seek reliable information to understand the implications of combining weight loss injections with contraceptive measures. Utilizing resources from reputable institutions can empower users to make informed choices that prioritize both their health and reproductive safety.

Nobody wants their weight loss plan to turn into a surprise pregnancy story.

Before you ignore random texts, see how Gmail users were targeted by a texting scam.